About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Nadroparin
- Procedure number
- PSUSA/00002104/202103
- Regulatory outcome
- Variation
Documents
Nadroparin : List of nationally authorised medicinal products - PSUSA/00002104/202103
English (EN) (317.19 KB - PDF)
Nadroparin : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002104/202103
English (EN) (55.04 KB - PDF)
български (BG) (71.63 KB - PDF)
español (ES) (31.32 KB - PDF)
čeština (CS) (50.15 KB - PDF)
dansk (DA) (30.44 KB - PDF)
Deutsch (DE) (31.17 KB - PDF)
eesti keel (ET) (30.83 KB - PDF)
ελληνικά (EL) (71.68 KB - PDF)
français (FR) (31.1 KB - PDF)
hrvatski (HR) (46.52 KB - PDF)
italiano (IT) (31.5 KB - PDF)
latviešu valoda (LV) (54.33 KB - PDF)
lietuvių kalba (LT) (51.57 KB - PDF)
magyar (HU) (47.65 KB - PDF)
Malti (MT) (51.09 KB - PDF)
Nederlands (NL) (126.95 KB - PDF)
polski (PL) (53.76 KB - PDF)
português (PT) (31.02 KB - PDF)
română (RO) (122.88 KB - PDF)
slovenčina (SK) (128.41 KB - PDF)
slovenščina (SL) (123.28 KB - PDF)
Suomi (FI) (30.29 KB - PDF)
svenska (SV) (30.62 KB - PDF)